anbesol maximum strength

Generic: benzocaine

Labeler: foundation consumer brands
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name anbesol maximum strength
Generic Name benzocaine
Labeler foundation consumer brands
Dosage Form GEL
Routes
TOPICAL
Active Ingredients

benzocaine 200 mg/g

Manufacturer
Foundation Consumer Brands

Identifiers & Regulatory

Product NDC 80070-220
Product ID 80070-220_2e81b590-9c95-4fcf-e063-6394a90ab555
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M022
Listing Expiration 2026-12-31
Marketing Start 2021-09-15

Pharmacologic Class

Established (EPC)
standardized chemical allergen [epc]
Chemical Structure
allergens [cs]
Physiologic Effect
increased histamine release [pe] cell-mediated immunity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 80070220
Hyphenated Format 80070-220

Supplemental Identifiers

RxCUI
238910 1052633
UNII
U3RSY48JW5
NUI
N0000185508 N0000175629 N0000184306 M0000728

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name anbesol maximum strength (source: ndc)
Generic Name benzocaine (source: ndc)
Application Number M022 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/g
source: ndc
Packaging
  • 1 TUBE in 1 BLISTER PACK (80070-220-33) / 9 g in 1 TUBE
source: ndc

Packages (1)

80070-220-33 1 TUBE in 1 BLISTER PACK (80070-220-33) / 9 g in 1 TUBE

Ingredients (1)

benzocaine (200 mg/g)

Linked Drug Pages (1)

Anbesol Maximum Strength ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "2e81b590-9c95-4fcf-e063-6394a90ab555", "openfda": {"nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "unii": ["U3RSY48JW5"], "rxcui": ["238910", "1052633"], "spl_set_id": ["dcc37403-0192-4658-bb7a-059273ce0047"], "pharm_class_cs": ["Allergens [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Foundation Consumer Brands"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 BLISTER PACK (80070-220-33)  / 9 g in 1 TUBE", "package_ndc": "80070-220-33", "marketing_start_date": "20210915"}], "brand_name": "Anbesol Maximum Strength", "product_id": "80070-220_2e81b590-9c95-4fcf-e063-6394a90ab555", "dosage_form": "GEL", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Increased Histamine Release [PE]", "Standardized Chemical Allergen [EPC]"], "product_ndc": "80070-220", "generic_name": "BENZOCAINE", "labeler_name": "Foundation Consumer Brands", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Anbesol", "brand_name_suffix": "Maximum Strength", "active_ingredients": [{"name": "BENZOCAINE", "strength": "200 mg/g"}], "application_number": "M022", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210915", "listing_expiration_date": "20261231"}